|
|
|
|
| LEADER |
05434nam a2200433 4500 |
| 001 |
on1126676582 |
| 003 |
OCoLC |
| 005 |
20200326101205.0 |
| 006 |
m o d |
| 007 |
cr cn|---unuuu |
| 008 |
191107s2019 ne a ob 001 0 eng |
| 040 |
|
|
|a AU@
|b eng
|e rda
|c AU@
|d OCLCO
|d OPELS
|d OCLCF
|d GrThAP
|
| 020 |
|
|
|a 9780128178744
|q hardcover
|
| 035 |
|
|
|a (OCoLC)1126676582
|
| 050 |
|
4 |
|a RC365
|
| 082 |
0 |
4 |
|a 616.8/3
|2 23
|
| 245 |
0 |
0 |
|a Molecular biology of neurodegenerative diseases :
|b visions for the future.
|n Part A /
|c edited by David B. Teplow.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a Amsterdam, The Netherlands :
|b Elsevier Academic Press,
|c 2019.
|
| 264 |
|
4 |
|c ©2019.
|
| 300 |
|
|
|a 1 online resource (xvii, 390 pages) :
|b illustrations (some colour).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Progress in molecular biology and translational science,
|x 1877-1173 ;
|v volume 168
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Preface / David B. Teplow -- Section I: Targetting AD. Chapter One. Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings / Kaj Blennow, Henrik Zetterberg -- Chapter Two. Tracking down a missing trigger for Alzheimer's disease by mass spectrometric imaging based on brain network analysis / Minako Hoshi -- Chapter Three. Using mirror-image peptides to enhance robustness and reproducibility in studying the amyloid [beta]-protein / Ariel J. Kuhn, Jevgenij A. Raskatov -- Section II: Etiology of AD. Chapter Four. In search of pathogenic amyloid [beta]-peptide in familial Alzheimer's disease / Michael S. Wolfe -- Chapter Five. Biology of splicing in Alzheimer's disease research / Kenichi Nagata, Takashi Saito, Takaomi C. Saido, Takashi Morihara -- Chapter Six. Acquired cerebral amyloid angiopathy: an emerging concept / Masahito Yamada, Tsuyoshi Hamaguchi, Kenji Sakai -- Section III: Neuroimmunology of AD. Chapter Seven. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease / Goran Šimić, Ena Španić, Lea Langer Horvat, Patrick R. Hof -- Chapter Eight. Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer's disease / Susan Westfall, Umar Iqbal, Maria Sebastian, Giulio Maria Pasinetti -- Chapter Nine. Neuroimmune interactions in Alzheimer's disease-New frontier with old challenges? / Stefan Prokop, Virginia M.Y. Lee, John Q. Trojanowski --
|
| 505 |
8 |
|
|a Section IV: AD therapy. Chapter Ten. Alzheimer's therapy development: a few points to consider / Einar M. Sigurdsson -- Chapter Eleven. The next steps in curing Alzheimer's disease / Fred W. van Leeuwen -- Chapter Twelve. Future horizons in Alzheimer's disease research / Thomas Wisniewski, Eleanor Drummond -- Chapter Thirteen. Why delay in effective treatment for Alzheimer's disease and related conditions / Khalid Iqbal, Fei Liu, ChengXin Gong, Chunling Dai, Wen Hu -- Chapter Fourteen. Restoring synaptic function through multimodal therapeutics / Raul Loera-Valencia, Muhammad-Al-Mustafa Ismail, Per Nilsson, Bengt Winblad -- Chapter Fifteen. Disease-modifying therapy for proteinopathies: can the exception become the rule? / Gal Bitan -- Chapter Sixteen. Combination therapy for Alzheimer's disease and related dementias / Martin M. Bednar -- Section V: Alpha-synucleinopathies. Chapter Seventeen. Can infections trigger alpha-synucleinopathies? / Christopher T. Tulisiak, Gabriela Mercado, Wouter Peelaerts, Lena Brundin, Patrik Brundin -- Chapter Eighteen. Prion-like propagation of [alpha]-synuclein in neurodegenerative diseases / Airi Tarutani, Masato Hasegawa -- Section VI: Model systems. Chapter Nineteen. Yeast models of neurodegenerative diseases / Mick F. Tuite.
|
| 520 |
|
|
|a "Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Volume 168 in the Progress in Molecular Biology and Translational Science series, provides the most topical, informative and exciting monographs available on a wide variety of research topics. The series includes in-depth knowledge on the molecular biological aspects of organismal physiology, with this release including chapters on Alzheimer's disease, Prion-like propagation of alpha-synuclein, What - if anything - can we learn about neurodegenerative diseases from yeast?, Mitochondrial rejuvenation and replacement as a novel strategy for treatment of age-related neurodegenerative diseases, Propagation and removal of cerebral amyloid angiopathy, and much more."--publisher's web page, viewed November 7, 2019.
|
| 588 |
|
|
|a Description based on online resource; title from publisher's web page (ScienceDirect, viewed November 7, 2019)
|
| 650 |
|
0 |
|a Nervous system
|x Degeneration
|x Molecular aspects.
|
| 650 |
|
0 |
|a Neurogenetics.
|
| 650 |
|
7 |
|a Nervous system
|x Degeneration
|x Molecular aspects.
|2 fast
|0 (OCoLC)fst01036094
|
| 650 |
|
7 |
|a Neurogenetics.
|2 fast
|0 (OCoLC)fst01036353
|
| 655 |
|
4 |
|a Electronic books
|
| 700 |
1 |
|
|a Teplow, David B.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version
|t Molecular biology of neurodegenerative diseases
|b First edition
|d Elsevier Academic Press, 2019
|z 9780128178744
|
| 830 |
|
0 |
|a Progress in molecular biology and translational science ;
|v v. 168.
|
| 856 |
4 |
0 |
|3 ScienceDirect
|u https://www.sciencedirect.com/science/bookseries/18771173/168
|z Full Text via HEAL-Link
|
